Evidence map›Paper›PMID 38095471›Full record

ArticleMicrobiology spectrum2024

Metagenomic next-generation sequencing of cell-free DNA for the identification of viruses causing central nervous system infections.

Yuying Lu, Ye Zhang, Zheng Lou, Xiaomin He, Qinghua Zhang, Qingxia Zhang, Shu Zhao, Han Chen, Haixia Zhu, Zhi Song and 3 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Yuying LuDepartment of Neurology, The Third Xiangya Hospital of Central South University , Changsha, China.
Ye ZhangDepartment of Scientific Affairs, Hugobiotech Co., Ltd. , Beijing, China.
Zheng LouDepartment of Scientific Affairs, Hugobiotech Co., Ltd. , Beijing, China.
Xiaomin HeDepartment of Scientific Affairs, Hugobiotech Co., Ltd. , Beijing, China.
Qinghua ZhangDepartment of Neurology, The Third Xiangya Hospital of Central South University , Changsha, China.
Qingxia ZhangDepartment of Neurology, The Third Xiangya Hospital of Central South University , Changsha, China.
Shu ZhaoDepartment of Neurology, The Third Xiangya Hospital of Central South University , Changsha, China.
Han ChenDepartment of Neurology, The Third Xiangya Hospital of Central South University , Changsha, China.
Haixia ZhuDepartment of Neurology, The Third Xiangya Hospital of Central South University , Changsha, China.
Zhi SongDepartment of Neurology, The Third Xiangya Hospital of Central South University , Changsha, China.
Ruxu ZhangDepartment of Neurology, The Third Xiangya Hospital of Central South University , Changsha, China.
Caiyu MaDepartment of Neurology, The Third Xiangya Hospital of Central South University , Changsha, China.ORCID 0000-0002-3682-6096
Ding LiuDepartment of Neurology, The Third Xiangya Hospital of Central South University , Changsha, China.ORCID 0000-0002-9214-7274
Central South University · CN

Funding

Wisdom Accumulation and Talent Cultivation Project of the Third xiangya hospital of Central South University No.YX202205
6 · The paper itself

Abstract

importanceThis study provides significant new data on the application of metagenomic next-generation sequencing (mNGS) to clinical diagnostics of central nervous system (CNS) viral infections, which can have high mortality rates and severe sequelae. Conventional diagnostic procedures for identifying viruses can be inefficient and rely on preconceived assumptions about the pathogen, making mNGS an appealing alternative. However, the effectiveness of mNGS is affected by the presence of human DNA contamination, which can be minimized by using cell-free DNA (cfDNA) instead of whole-cell DNA (wcDNA). This multi-center retrospective study of patients with suspected viral CNS infection found that mNGS using cfDNA had a significantly lower proportion of human DNA and higher sensitivity for detecting viruses than mNGS using wcDNA. Herpesviruses, particularly VZV, were found to be the most common DNA viruses in these patients. Overall, mNGS using cfDNA is a promising complementary diagnostic method for detecting CNS viral infections.

Indexed as

Cell-Free Nucleic AcidsCentral Nervous System InfectionsVirus DiseasesVirusesDNAHigh-Throughput Nucleotide SequencingHumansMetagenomicsRetrospective StudiesCell-Free Nucleic AcidsDNAcell-free DNAcentral nervous system infectioncerebrospinal fluidherpesvirusmetagenomic sequencing

Identifiers

PMID38095471
PMCPMC10783088
OpenAlexW4389732596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.